Compounded Tirzepatide: Issues for Supply and Demand
The U.S. Food and Drug Administration (FDA) has recently reinforced regulations prohibiting compounding pharmacies from producing generic versions of Zepbound and Mounjaro, both of which contain the active ingredient Tirzepatide. These medications, initially developed...